~~<i id='16A67FD7B2'><strike id='16A67FD7B2'><tt id='16A67FD7B2'><pre id='16A67FD7B2'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：fashion 2025-10-02 02:47:37 Page View：861

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Death toll from an explosion and collapse of a Paris building in June climbs to 3
Next article： Drug repurposing or repositioning? The language matters

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Providers still hesitate to prescribe buprenorphine, study finds

Anurseholdstabsofbuprenorphine.EliseAmendola/APSignificantchallengesremainbeforemostAmericanclinicia

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Court strikes down limits on filming of police in Arizona

FILE-PhoenixPolicestandinfrontofpoliceheadquartersonMay30,2020,inPhoenix,waitingforprotestersmarchin